PDE-4 inhibitors could be one of the alternative therapies for the management of IBS, since in clinical trials, one of the PDE-4 inhibitors, tetomilast, has shown some benefit for the treatment of inflammatory bowel disease [15]. This evidence concerns the gene PDE4A and inflammatory bowel disease.